Navigation Links


Come at Biology News

Growth in the sea comes down to a struggle for iron

Scientists know that injecting iron into some major regions of the oceans can stimulate the growth of diatoms and other phytoplankton, but something odd occurs as these tiny marine plants continue to grow. They begin to starve in the midst of plenty, acting as though iron, an essential nutrient, still is in short supply. Why this happens is unclear, but the answer could be that iron sets off a ki...

Improved Outcomes Releases GeneLinker(TM) Gold and Platinum Version 4.6

Improved Outcomes Software (IOS) todayannounced the release of GeneLinker(TM) Gold and Platinum 4.6, newversions of the award-winning Gene Expression and Proteomics AnalysisSoftware products."The new releases are focused primarily on importing and analyzingprotein biomarker data, a high priority for many of our customers. Forexample, we have integrated the Protein Biomarker Package into the...

Tiny scaffolding allows stem cells to become working fat cells

Researchers here have used a new microscopic, three-dimensional scaffolding to coax mouse stem cells to transform themselves into fat cells, and then to function identical to how fat cells naturally do in the body. While other studies have previously grown fat cells, or adipocytes, in the laboratory, those cells never completely functioned in the same way they do in normal tissue. They fai...

South America's vast pantanal wetland may become next everglades, UNU experts warn

South America's giant Pantanal wetlands, one of the world's most bio-diverse ecosystems, is at growing risk from intensive peripheral agricultural, industrial and urban development ?problems expected to be compounded by climate change, United Nations University experts warn. Covering more than 165,000 square kilometers ?an area roughly equal to Florida ?in the heart of South America, the P...

BioMed Central welcomes the new National Institutes of Health public access policy

BioMed Central welcomes the announcement of the US National Institutes of Health (NIH) new public access policy. The NIH calls on all of i...

More>>

Come at Biology Products

CometSlide from R&D Systems

Description:Request Info...
Company:R&D Systems
Come at Biology Technology

Eppendorf Electroporation Application Notes Your participation is highly welcome !!!

E-mail us your application notes for inclusion in this Eppendorf web page. Each contribution published will be acknowledged with a set of electroporation cuvettes. ...

Eppendorf Electroporation Application Notes Your participation is highly welcome !!!

E-mail us your application notes for inclusion in this Eppendorf web page. Each contribution published will be acknowledged with a set of electroporation cuvettes. ...

British come to Madison; UW starts stem-cell programs

The British are interested in bio and life science investments in the United States and they're looking at Wisconsin. Meanwhile the University of Wisconsin-Madison is introducing two new interdisciplinary stem-cell research programs. <a href="http://www.wistech...

Rockwell Q2 operations net income soars, shares plunge

Income from continuing operations at Milwaukee-based Rockwell Automation Inc. for the quarter ended March 31 rose to $142.5 million, a 90 percent leap from the $74.9 million the company earned the same quarter of 2004. Profit for the second quarter of 2005, including discontinued operations, was an even $150 million, compared to $78.3 million a year ago. Despite that, Rockwell s...

Ethics Board site offers welcome contrast to state IT mistakes

There's probably no need to hit the Control Z keys to undo all...

More>>

Come at Biology Definition

Glycome

.The glycome may in fact be one of the most complex entities in nature. The glycome is studied by glycobiology sometimes referred to as . The...
Come at Biology Dictionary

Sarcomere

saturated fat A fat with single covalent bonds between the carbons of its <a href="/ ?q=/ Biology-Dictionary/ fat...

Glycome

The is studied by glyco<a href="/ ...
Come at Medicine News

Now AIDS treatment comes dirt-cheap

The war of the pharmaceutical giants has just begun. After waging wars over many drug formulations the pharma majors are now locking horns over AIDS treatment. The ball was set in motion by the dramatic announcement of Indian firm Cipla that a three-drug combination for AIDS treatment would cost less than a U.S. dollar a day. Not to be left far behind rival firm Ranbaxy announced...

Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis

The sad part in the treatment of certain cancers, hepatitis and multiple sclerosis with interferon therapy is that while the treatment can extent life, it can seriously spoil its quality. Alpha interferon a drug used to fight these diseases can cause crippling depression. A new research now shows that the use of an antidepressant before starting the treatment can avoid this problem. Al...

Antifever drug betters stroke outcome

Over-the-counter pain reliever and fever reducer Paracetamol, whose active ingredient is Acetaminophen is found effective in the prognosis of the stroke. The fever-reducer acetaminophen lowers body temperature in people who have had a stroke, according to a new study conducted in The Netherlands. Rise in the body temperature during the first few days, though small enough that they hardly...

Doctor samples come under the ambit of advertisement

The supreme court of India has declared that distribution of physician's sample by pharmaceutical companies to the medical profession is in nature of advertisement expenditure falling within restrictive provisions of sub section (3A) of section 37 of Income Tax Act. The nature of the advertisement or publicity depends upon the nature and quality of the article in question. The p...

Heart Is Better Off For Watching Comedy Films

The blood flow to the heart improves as one watches more comedy films, which makes a person laugh, according to a recent research. Researchers asked 20 healthy young adults to watch 15 to 30 minute segments of sad and humorous films, a minimum of 48 hours apart. // Participants were asked to abstain from drinking alcohol, using vitamins or herbs, or taking aerobic exercise the evenin...

More>>

Come at Medicine Products

PICOMEnterprise -Brokerless Multi-Department PACS

Description:ScImage's PICOMEnterprise is a web-enabled PACS that has built-in visualization tools, custom reporting and custom workflow integration. It is a multi-modality solution that captures, stores, distributes and archives images, reports and clinical data generated from any DICOM and many non-DICOM devices and gives Cardiologists a single point of entry to assess their patients' conditions....
Company:ScImage

Comet XL Lab-based EEG - Recording & Review

Description:Comet XL is a complete EEG system designed to satisfy the needs of the physician's office, hospital, or medical center. Ready to use, Comet XL is supplied with the latest high performance PC and Photic Stimulator. Select from various mobile carts, cabinets and monitor sizes to suit your individual needs. These powerful, easy-to-use EEG systems consist of the high response 50-channel AS40 Amplifie...
Company:Grass Technologies
Come at Medicine Technology

Prothrombin Time Comes in Small (CLIA-Waived) Packages

Determining prothombin levels is necessary to plan or evaluate anticoagulant therapy, to diagnose various inherited conditions, such as hyperhomocystinemia, elevated factor VIII levels, dysfibrinogenemia, factor XII deficiency and disorders of plasmin generation, and to assess acquired conditions, such as pregnancy, postoperative state, antiphospholipid syndrome, hyperhomocystinemia, among ot...

Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients

PHILADELPHIA, July 3, 2007-- – The appearance of arash in cancer patients treated with erlotinib (Tarceva) isstrongly associated with longer survival, according to researchersfrom the drug’s developer, OSI Pharmaceuticals, Inc. This isnot the first time that rash has been associated with a survivaladvantage with EGFR inhibitors – a class of drugs whichincludes erlotinib...

Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants

RICHMOND, Va.--(BUSINESS WIRE)--Jun 26, 2007 - Insmed Incorporated(Nasdaq:INSM), a biopharmaceutical company focused on thedevelopment and approval of drugs for the treatment of metabolicdiseases with unmet medical needs, today noted the publication ofpromising results of research from three universities regarding thepotential role of insulin-like growth factor binding protein-3(IGFBP-3) in...

MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions

Data from the PROactive and CHICAGO studies of ACTOS(R)(pioglitazone HCl) will be presented in poster format at the 67thScientific Sessions of the American Diabetes Association inChicago: -- Hospitalizations for serious adverse events in high-risk type 2 diabetes patients treated with pioglitazone for 3...

New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings

Registry Analysis Published in Journal Heart Finds Taxus Stent,Implantation of Multiple Stents and Small Vessel Size To BeIndependent Predictors of Need for Another Procedure MIAMI LAKES, Fla., June 4, 2007 /PRNewswire via COMTEX NewsNetwork/ -- An analysis of data from the Western Denmark HeartRegistry found that patients who received the CYPHER(R)Sirolimus-eluting Coronary...

More>>

Come at Medicine Dictionary

Comedones

<A href="http:/ / www...

Comedo

a rough texture. The bumps are found at the opening of a sebaceous follicle (<a href="/ ?q=/ Medicine-Dictiona...
Other TagsWesternWesternWesternWesternWestern
(Date:10/11/2008)... Barnett International, a... has announced the release of The Form FDA 1572: A...s, and Monitors. Designed for clinical investigato...y affairs professionals, and others involved in th... reference guide to address the Form FDA 1572-Stat...
(Date:10/10/2008)... PACO Communications Named Agency ...gian American Hospital has just,announced the laun...signed,to build awareness of its long-standing com... and care through its Labor and Delivery, Special ... rolled out in Chicago with a focus on public rela...
(Date:10/10/2008)...1 in 6 likely to develop some form of disease by 2...FRIDAY, Oct. 10 (HealthDay News) -- Liver transpla... the general population, say researchers in Finlan...ssue of Liver Transplantation , researchers inves...er transplant recipients from Helsinki University ...
(Date:10/10/2008)... MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall/...unces that it has appointed William,(Bill) Federic...ard to five,members., Mr. Federici joined West Ph...Financial Officer in August of 2003. Under his fin...have grown to more than $1.0 billion from,$300 mil...
Breaking Medicine News(10 mins):Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 2Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 3Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 2Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 3Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3
(Date:10/10/2008)...Haven, Conn. Yale scientists have created nanowir...ronics that are both sensitive and specific enough...ion, according to a report in Nano Letters . , ...ly specific antigens signatures of bacteria, viru... are activated, they produce acid, and generate a ...
(Date:10/9/2008)...NTA CLARA, Calif., Oct. 9 /PRNewswire-FirstCall/ -...ading developer of human interface,solutions for m... devices,announced today that it will report fina... on Thursday, October 23, 2008 after the close of ...erence call for analysts and,investors at 2:00 p.m...
(Date:10/9/2008)...It,s hard being a mussel: you have to worry about ...ention an environment that can change your body te...s. , "It,s one of the most variable habitats on ... can spend part of the day bathed in cool Pacific ...rnia sun." , Gracey led the first real-time mole...
(Date:10/9/2008)...National Institute of Allergy and Infectious Disea...alth (NIH), will award five-year contracts estimat... in Systems Biology for Infectious Disease Researc...h facility will apply novel techniques to study di...ome (SARS), tuberculosis and influenza. , System...
Breaking Biology News(10 mins):Sensitive nanowire disease detectors made by Yale scientists 2Synaptics to Report First Quarter Results on October 23 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3New Systems Biology Awards enable detailed study of microbes 2Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 1Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 2Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 1Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 2Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 1Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 1Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 3Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 4Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 5Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 6Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 7
Other Contentsabortionabortionabortionabortioninevitableinevitableinevitableinevitablereflexesreflexesreflexesdistressdistressdistressbotulismbotulismbotulisminfarctinfarctinfarctinfantsinfantsinfantsinfantsinfantsinfantsinfantileinfantile